Multifamily group psychoeducation and cognitive remediation for first-episode psychosis: a randomized controlled trial

Nicholas Jk Breitborde, Francisco A Moreno, Natalie Mai-Dixon, Rachele Peterson, Linda Durst, Beth Bernstein, Seenaiah Byreddy, William R McFarlane, Nicholas Jk Breitborde, Francisco A Moreno, Natalie Mai-Dixon, Rachele Peterson, Linda Durst, Beth Bernstein, Seenaiah Byreddy, William R McFarlane

Abstract

Background: Multifamily group psychoeducation (MFG) has been shown to reduce relapse rates among individuals with first-episode psychosis. However, given the cognitive demands associated with participating in this intervention (e.g., learning and applying a structured problem-solving activity), the cognitive deficits that accompany psychotic disorders may limit the ability of certain individuals to benefit from this intervention. Thus, the goal of this study is to examine whether individuals with first-episode psychosis who participate simultaneously in MFG and cognitive remediation--an intervention shown to improve cognitive functioning among individuals with psychotic disorders--will be less likely to experience a relapse than individuals who participate in MFG alone.

Methods/design: Forty individuals with first-episode psychosis and their caregiving relative will be recruited to participate in this study. Individuals with first-episode psychosis will be randomized to one of two conditions: (i) MFG with concurrent participation in cognitive remediation or (ii) MFG alone. The primary outcome for this study is relapse of psychotic symptoms. We will also examine secondary outcomes among both individuals with first-episode psychosis (i.e., social and vocational functioning, health-related quality of life, service utilization, independent living status, and cognitive functioning) and their caregiving relatives (i.e., caregiver burden, anxiety, and depression)

Discussion: Cognitive remediation offers the possibility of ameliorating a specific deficit (i.e., deficits in cognitive functioning) that often accompanies psychotic symptoms and may restrict the magnitude of the clinical benefits derived from MFG.

Trial registration: ClinicalTrials (NCT): NCT01196286.

Figures

Figure 1
Figure 1
Patient Flow Diagram

References

    1. Crumlish N, Whitty P, Clarke M, Browne S, Kamali M, Gervin M, McTigue O, Kinsella A, Waddington JL, Larkin C, O'Callaghan E. Beyond the critical period: Longitudinal study of 8-year outcome in first-episode non-affective psychosis. British Journal of Psychiatry. 2009;194
    1. Lieberman JA, Perkins D, Belger A, Chakos M, Jarskog F, Boteva K, Gilmore J. The early stages of schizophrenia: Speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biological Psychiatry. 2001;50:884–897.
    1. McGlashan TH. A selective review of recent North American follow-up studies on schizophrenia. Schizophrenia Bulletin. 1998;14:515–542.
    1. Birchwood M. In: The Recognition and Management of Early Psychosis: A Preventative Approach. Jackson HJ, editor. Port Chester, NY: Cambridge University Press; 1999. Early intervention in psychosis: The critical period; pp. 226–264.
    1. Birchwood M, Fiorillo A. The critical period for early intervention. American Journal of Psychiatric Rehabilitation. 2000;4:182–198.
    1. Birchwood M, Todd P, Jackson C. Early intervention in psychosis: The critical period hypothesis. British Journal of Psychiatry. 1998;172:53–59.
    1. Reading B, Birchwood M. Early intervention in psychosis: Rationale and evidence for effectiveness. Disease Management and Health Outcomes. 2005;13:53–63.
    1. McFarlane WR, Dixon L, Lukens E, Lucksted A. Family psychoeducation and schizophrenia: A review of the literature. Journal of Marital and Family Therapy. 2003;29:223–245.
    1. Pilling S, Bebbington P, Kuipers E, Garety P, Geddes J, Orbach G, Morgan C. Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychological Medicine. 2002;32:763–782.
    1. Pitschel-Walz G, Leucht S, Bauml J, Kissling W, Engel RR. The effect of family interventions on relapse and rehospitalization in schizophrenia--A meta-analysis. Schizophrenia Bulletin. 2001;27:73–92.
    1. McFarlane WR. Multifamily groups in the treatment of severe psychiatric disorders. New York: Guilford Press; 2002.
    1. Goldstein MJ. Psycho-education and family treatment related to the phase of a psychotic disorder. International Clinical Psychopharmacology. 1996;11(suppl 2):77–83.
    1. McFarlane WR, Lukens E, Link B, Dushay R, Deakins SA, Newmark M, Dunne EJ, Horen B, Toran J. Multiple-family groups and psychoeducation in the treatment of schizophrenia. Archives of General Psychiatry. 1995;52:679–687.
    1. McFarlane WR, Link B, Dushay R, Marchal J, Crilly J. Psychoeducational multiple family groups: Four-year relapse outcome in schizophrenia. Family Process. 1995;34:127–144.
    1. Bertelsen M, Jeppesen P, Petersen L, Thorup A, Øhlenschlæger J, le Quach P, Christensen TO, Krarup G, Jørgensen P, Nordentoft M. Five-year follow-up of a randomized multicenter trial of intensive intervention vs standard treatment for patients with a first episode of psychotic illness: The OPUS study. Archives of General Psychiatry. 2008;65:762–771.
    1. Fjell A, Thorsen GRB, Friis S, Johannessen JO, Larsen TK, Lie K, Lyse HG, Melle I, Simonsen E, Smeby NA, Øxnevad AL, McFarlane WR, Vaglum P, McGlashan T. Multifamily group treatment in a program for patients with first-episode psychosis: Experiences from the TIPS project. Psychiatric Services. 2007;58:171–173.
    1. Kuipers E. Psychological therapies for schizophrenia: Family and cognitive interventions. Psychiatric Times. 2007;29:1–8.
    1. Green MF, Kern RF, Braff DL, Mintz JL. Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the "right stuff"? Schizophrenia Bulletin. 2000;26:119–136.
    1. Green MF. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. Journal of Clinical Psychiatry. 2006;67(suppl 9):3–8.
    1. Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: A qualitative review of the evidence. Neuropsychology. 1998;12:426–445.
    1. Gold JM. Cognitive deficits as treatment targets in schizophrenia. Schizophrenia Research. 2004;72:21–28.
    1. Gold JM, Green MF. In: Comprehensive Textbook of Psychiatry. Sadock VA, editor. Maryland: Lippincott, Williams, & Wilkins; Neurocognition in schizophrenia.
    1. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia. American Journal of Psychiatry. 1996;153:321–330.
    1. Browne M, Peer J, Spaulding W. Best practice guidelines for cognitive rehabilitation for people with serious mental illness.
    1. APA/CAAP Task Force on Serious Mental Illness and Severe Emotional Disturbance. Training grid outlining best practices for people with serious mental illness. 2005.
    1. McGurk SR, Twamley EW, Sitzer DI, McHugo GJ, Mueser KT. A meta-analysis of cognitive remediation in schizophrenia. American Journal of Psychiatry. 2007;164:1791–1802.
    1. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition with Psychotic Screen (SCID-I/P W/PSY SCREEN) New York: Biometrics Research, New York State Psychiatric Institute; 2002.
    1. Perkins DO, Leserman J, Jarskog LF, Graham K, Kazmer J, Lieberman JA. Characterizing and dating the onset of symptoms in psychotic illness. Schizophrenia Research. 2002;44:1–10.
    1. Breitborde NJK, Srihari VH, Woods SW. Review of the operational definition of first-episode psychosis. Early Intervention in Psychiatry. 2009;3:259–265.
    1. Kessler RC, Amminger GP, Aguilar-Gaxiola S, Alonso J, Lee S, Üstün TB. Age of onset of mental disorders: A review of recent literature. Current Opinion in Psychiatry. 2007;20:359–364.
    1. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS. Lifetime and 12-month prevalence of DSM-III--R psychiatric disorders in the United States: Results from the National Comorbidity Study. Archives of General Psychiatry. 1994;51:8–19.
    1. Iacono WG, Beiser M. Where are the women in first-episode studies of schizophrenia. Schizophrenia Bulletin. 1992;18:471–280.
    1. Cook JA. Who "mothers" the chronically mentally ill? Family Relations. 1988;37:42–49.
    1. Lenth RV. Some practical guidelines for effective sample size determination. American Statistician. 2001;55:187–193.
    1. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequence of treatment. New England Journal of Medicine. 1988;318:1728–1733.
    1. Kraemer HC, Kupfer DJ. Size of treatment effects and their importance to clinical research and practice. Biological Psychiatry. 2006;59:990–996.
    1. Champely S. pwr: Basic functions for power analysis. 2007.
    1. R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2008.
    1. Lehman AF, Steinwachs DM. the Co-Investigators of the PORT Project. At issue: Translating research into practice: The Schizophrenia Patient Outcomes Research Treatment Recommendations. Schizophrenia Bulletin. 1998;24:1–10.
    1. Lehman AF, Kreyenbuhl J, Buchanan RW, Dickerson FB, Dixon LB, Goldberg R, Green-Paden LD, Tenhula WN, Boerescu D, Tek C, Sandson N, Steinwachs DM. The Schizophrenia Patient Outcomes Research Team (PORT): Updated treatment recommendations 2003. Schizophrenia Bulletin. 2004;30:193–217.
    1. Bracy O. PSS CogRehab Software, Version 95. Indianapolis, IN: Psychological Software Services, Inc; 1995.
    1. Kurtz MM, Seltzer JC, Shagan DS, Thime WR, Wexler BE. Computer-assisted cognitive remediation in schizophrenia: What is the active ingredient? Schizophrenia Research. 2007;89:251–260.
    1. Greig TC, Zito W, Wexler BE, Fiszdon J, Bell MD. Improved cognitive function in schizophrenia after one year of cognitive training and vocational services. Schizophrenia Research. 2007;96:156–161.
    1. Bell M, Bryson G, Greig T, Corcoran C, Wexler BE. Neurocognitive enhancement therapy with work therapy: Effects on neuropsychological test performance. Archives of General Psychiatry. 2001;58:763–768.
    1. Fiszdon JM, Bryson GJ, Wexler BE, Bell MD. Durability of cognitive remediation training in schizophrenia: Performance on two memory tasks at 6-month and 12-month follow-up. Psychiatry Research. 2004;125:1–7.
    1. Fiszdon JM, Cardenas AS, Bryson GJ, Bell MD. Predictors of remediation success on a trained memory task. Journal of Nervous and Mental Disease. 2005;193:602–608.
    1. Fiszdon JM, Choi J, Bryson GJ, Bell MD. Impact of intellectual status on response to cognitive task training in patients with schizophrenia. Schizophrenia Research. 2006;87:261–269.
    1. Hogarty GE, Flesher S, Ulrich R, Carter M, Greenwald D, Pogue-Geile M, Keshavan M, Cooley S, DiBarry AL, Garrett A, Parepally H, Zoretich R. Cognitive enhancement therapy for schizophrenia. Effects of a 2-year randomized trial on cognition and behavior. Archives of General Psychiatry. 2004;61:866–876.
    1. Eack SM, Greenwald DP, Hogarty SS, Cooley SJ, DiBarry AL, Montrose DM, Keshavan MS. Cognitive enhancement therapy for early-course schizophrenia: Effects of a two-year randomized controlled trial. Psychiatric Services. 2009;60:1468–1476.
    1. Eack SM, Hogarty GE, Greenwald DP, Hogarty SS, Keshavan MS. Cognitive enhancement therapy improves emotional intelligence in early course schizophrenia: Preliminary effects. Schizophrenia Research. 2007;89:308–311.
    1. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale for schizophrenia. Schizophrenia Bulletin. 1987;10:288–298.
    1. Nuechterlein KH, Miklowitz DJ, Ventura J, Gitlin MJ, Stoddard M, Lukoff D. Classifying episodes in schizophrenia and bipolar disorder: Criteria for relapse and remission applied to recent-onset samples. Psychiatry Research. 2006;144:153–166.
    1. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychological Reports. 1962;10:799–812.
    1. Bell M, Milstein R, Beam-Goulet J, Lysaker P, Cicchetti D. The positive and negative syndrome scale and the brief psychiatric rating scale: Reliability, comparability, and predictive validity. Journal of Nervous and Mental Disease. 1992;180:723–728.
    1. Liberman RP, Kopelowicz A, Ventura J, Gutkind D. Operational criteria and factors related to recovery from schizophrenia. International Review of Psychiatry. 2002;14:256–272.
    1. Birchwood M, Smith J, Cochrane R, Wetton S, Copestake S. The social functioning scale: The development and validation of a new scale for social adjustment for use in family intervention programmes with schizophrenic patients. British Journal of Psychiatry. 1990;157:853–859.
    1. Mausbach BT, Harvey PD, Goldman SR, Jeste DV, Patterson TL. Development of a brief scale of everyday functioning in persons with serious mental illness. Schizophrenia Bulletin. 2007;33:1364–1372.
    1. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey. Health Economics. 1993;2:217–227.
    1. Rosenheck RA, Leslie DL, Sindelar J, Miller EA, Lin H, Stroup TS, McEvoy J, Davis SM, Keefe RSE, Swartz M, Perkins DO, Hsiao JK, Lieberman JA. Cost-effectiveness of second generation antipsychotics and perphenainze in a randomized trial of treatment for chronic schizophrenia. American Journal of Psychiatry. 2007;163:2080–2089.
    1. Palmer BW, Heaton RK, Gladsjo JA, Evans JD, Patterson TL, Golshan S, Jeste DV. Heterogeniety in functional status among older outpatients with schizophrenia: Employment history, living situations, and driving. Schizophrenia Research. 2002;55:205–215.
    1. Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, Essock S, Fenton WS, Freese FJI, Gold JM, Goldberg T, Heaton RK, Keefe RSE, Kraemer H, Mesholam-Gately R, Seidman LJ, Stover E, Weinberger DR, Young AS, Zalcman S, Marder SR. The MATRICS consensus cognitive battery, part 1: Test selection, reliability, and validity. American Journal of Psychiatry. 2008;165:203–213.
    1. White T, Stern RA. Neuropsychological Assessment Battery: Psychometric and technical manual. Lutz, FL: Psychological Assessment Resources, Inc; 2003.
    1. Cuijpers P. The effects of family interventions on relatives' burden: A meta-analysis. Journal of Mental Health. 1999;8:275–285.
    1. Hazel NA, McDonell MG, Short RA, Berry CM, Voss WD, Rodgers ML, Dyck DG. Impact of multiple-family groups for outpatients with schizophrenia on caregivers' distress and resources. Psychiatric Services. 2004;55:35–41.
    1. Reinhard SC, Gubman GD, Horwitz AV, Minsky S. Burden Assessment Scale for families of the seriously mentally ill. Evaluation and Program Planning. 1994;17:261–269.
    1. Beck AT, Steer RA, Ball R, Ranieri WF. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. Journal of Personality Assessment. 1996;67:588–597.
    1. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: Psychometric properties. Journal of Consulting and Clinical Psychology. 1988;56:893–897.
    1. Montori VM, Guyatt GH. Intention-to-treat principle. Canadian Medical Association Journal. 2001;165:1339–1341.
    1. Fisher RA. Statistical methods for research workers. New York: Hafner; 1970.
    1. Overall JE. Continuity correction for Fisher's exact probability test. Journal of Educational Statistics. 1980;5:177–190.
    1. Vickers AJ, Altman DG. Analysing controlled trials with baseline and follow up measurements. BMJ. 2001;323:1123–1124.
    1. Breitborde NJK, Woods SW, Srihari VH. Multifamily psychoeducation for first-episode psychosis: A cost-effectiveness analysis. Psychiatric Services. 2009;60:1477–1483.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere